WellPoint Inc (WLP): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

WellPoint ( WLP) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 1%. By the end of trading, WellPoint rose $1.19 (1.9%) to $62.93 on average volume. Throughout the day, 3.2 million shares of WellPoint exchanged hands as compared to its average daily volume of 3.7 million shares. The stock ranged in a price between $61.62-$63.63 after having opened the day at $61.63 as compared to the previous trading day's close of $61.74. Other companies within the Health Services industry that increased today were: Given Imaging ( GIVN), up 19.1%, USMD Holdings ( USMD), up 7.9%, Unilife Corporation ( UNIS), up 7.4%, and Concord Medical Services Holdings ( CCM), up 6.4%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. The company offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $20.17 billion and is part of the health care sector. The company has a P/E ratio of 8.4, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 6.8% year to date as of the close of trading on Wednesday. Currently there are nine analysts that rate WellPoint a buy, no analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Align Technology ( ALGN), down 20.4%, ImmunoCellular Therapeutics ( IMUC), down 14.1%, Hansen Medical ( HNSN), down 7.1%, and Harvard Bioscience ( HBIO), down 6.7%, were all laggards within the health services industry with Covidien ( COV) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.

null

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists